North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research - Wikidata - awgldk - TriplyDB

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

http://www.wikidata.org/entity/Q22242834

about

The empirical status of the ultra high-risk (prodromal) research paradigm Realistic expectations of prepulse inhibition in translational models for schizophrenia research.Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome Working with Asian American youth at clinical high risk for psychosis: a case illustration Stress and neurodevelopmental processes in the emergence of psychosis How can studies of resting-state functional connectivity help us understand psychosis as a disorder of brain development?Developmental mechanisms in the prodrome to psychosis North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia Early Recognition of High Risk of Bipolar Disorder and Psychosis: An Overview of the ZInEP "Early Recognition" Study.Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.Emotion processing in persons at risk for schizophrenia.Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011 Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study.Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies.How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-up Glycine treatment of the risk syndrome for psychosis: report of two pilot studies The development of psychotic disorders in adolescence: a potential role for hormones Youth-caregiver agreement on clinical high-risk symptoms of psychosis.Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trial Recent advances in understanding schizophrenia Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial Negative symptoms in individuals at clinical high risk of psychosis.The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.Current status specifiers for patients at clinical high risk for psychosis.Practitioner review: schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents--evidence-based management approaches.Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome."Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debate Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort Prevention of the first episode of psychosis.Strategies for effective recruitment of individuals at risk for developing psychosis At clinical high risk for psychosis: outcome for nonconverters.Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis Premorbid functional development and conversion to psychosis in clinical high-risk youths.Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.

P2860

Q22242833-2396C87D-CA3B-436E-885E-5A6AFD116F62 Q24645703-C2B41656-DBB1-4B8B-90B7-B94C862F145B Q26824150-984BDF09-4C6D-4DFB-9BF0-8E0C1A5D2F16 Q26827530-004E7F0D-4CD7-4DCF-9035-9122FEAAE8E8 Q26830600-7EA28246-1C28-482A-AE39-E3B26539D2A4 Q27008055-92239162-7D50-4E2C-89C2-8D3A0DE32657 Q27009237-07E2D66C-4A95-4489-A4E6-5BC4414A0CF1 Q27011767-E03F1AC6-D4D2-4D70-92E5-E8012FD3FD05 Q28727584-A4C39B48-5212-4154-8431-A54636CDCF5E Q30390500-48B1F68A-CB48-41FF-ABA0-7CBD438C53CB Q30465425-D45A3688-AB02-4DDA-8B08-CA5BB432699E Q30487300-AD569A5D-2443-46B3-BB93-903DFD399E85 Q30650589-D340C9C0-484B-4AA1-BDCE-CC8D051794BC Q30655449-43CF6500-6DC7-450E-AC83-98C877B70F9D Q31120585-416EEB6B-9805-4374-94FC-38FDB77062DB Q33566091-435F745B-1C19-4E9E-A8EE-ACE3B323C930 Q33637911-58A8677F-AE46-41D0-8EE1-9142A167EA67 Q33806650-FC8C7B19-4EE9-4FF5-B8BD-3BA924F6EEBF Q33820520-E9BF3B1B-AEC6-42AD-BE32-8B6CB88D1030 Q33892036-85501128-6B91-42CC-88E9-B946867A53CB Q33942094-D440AE9A-993D-4850-8E0A-9A257111E740 Q33954717-857D5AC9-F512-426C-BCEC-410AE4AF51BB Q33992721-F45F2D81-D8F2-42A4-BA34-2907D5885F22 Q34071212-1A4A3498-F6A9-4499-8F52-F5EC8EB79F78 Q34122956-97FAAFEB-12DC-446B-9FBB-BCE01AFFD78F Q34123531-D7C4336F-8D12-405B-A4AB-29B88ACD17D1 Q34376032-9DDBD8D2-7E2C-43D7-9CA1-E95AB7AD2530 Q34501767-9ECA891F-4A40-42D3-8B6D-39D710F2B08C Q34586836-B6DB6610-295C-4527-8EE7-0FFE7A360B9A Q34604254-71884FC5-CC33-4891-B93C-F5C6C892D586 Q34623331-A8B8182C-B46E-4991-95D8-90C4BCA333BB Q34664735-855B7B31-A134-4B32-A517-353927E7AEA8 Q34727780-1370DFF0-DB7E-4ACC-9001-FDD4B4C3DE40 Q34776827-A6938D41-77E4-4396-AEEA-41E41F317DCB Q35132114-35FE34E0-4FF0-4C1E-966D-196B1D950315 Q35148454-129BBC11-E96C-4CEC-BB3F-A7121288B73F Q35166842-8401A657-1881-47B6-878C-F5062BEB6DA9 Q35168094-E9574EA1-5A09-408A-83D9-701AD413C439 Q35168098-CF7E5190-64C3-40C0-903C-36CC5356BF0E Q35185253-6592F49C-6223-41D4-AE27-8B3D44CDAB7F

P2860

North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research

http://www.wikidata.org/entity/Q22242834

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

North American Prodrome Longit ...... odromal schizophrenia research

@ast

North American Prodrome Longit ...... odromal schizophrenia research

@en

North American Prodrome Longit ...... odromal schizophrenia research

@en-gb

North American Prodrome Longit ...... odromal schizophrenia research

@nl

type

label

North American Prodrome Longit ...... odromal schizophrenia research

@ast

North American Prodrome Longit ...... odromal schizophrenia research

@en

North American Prodrome Longit ...... odromal schizophrenia research

@en-gb

North American Prodrome Longit ...... odromal schizophrenia research

@nl

prefLabel

North American Prodrome Longit ...... odromal schizophrenia research

@ast

North American Prodrome Longit ...... odromal schizophrenia research

@en

North American Prodrome Longit ...... odromal schizophrenia research

@en-gb

North American Prodrome Longit ...... odromal schizophrenia research

@nl

P1433

Q22242834-7B1C5691-7D0A-4ECC-A3DB-433E532791AA

P1476

Q22242834-B40085E7-A17A-4C90-A4B9-AA4C9C5163B3

P2093

Q22242834-1AA2ADA9-80F5-498D-97F7-8CB3C480637F

Q22242834-758706CD-9974-4027-B545-C10477A9009D

Q22242834-7AA9B021-8402-4A66-B306-8AF122E0BA7B

Q22242834-7D8588AF-EDEA-46A7-9269-652AF176F46E

Q22242834-F2F802F7-F35A-48A9-9EDA-07C00E31B4D3

Q22242834-FFA3405B-D208-4A64-97BD-7AE91D94B0D7

P2860

Q22242834-18644E61-6F4F-4B93-9B01-0BBCA4B22894

Q22242834-278D943A-B003-426F-BC86-75D5752FC9F7

Q22242834-5F6C50BA-88C3-4383-BCE7-D58D9091C04F

Q22242834-667F7F1F-C9D9-4ADC-A43B-105C1250A633

Q22242834-8D7ADB27-3788-4E29-A93B-2FC224006475

Q22242834-C4EC3E90-C1FD-4632-97ED-549A7B62086C

Q22242834-D2D02C0A-E9D2-4E80-9DB9-C74B55427728

Q22242834-D51177D4-1175-4ECB-BE93-D49FF70C7DDD

Q22242834-D730AC51-304C-4341-80F0-0D44C64C5BA7

Q22242834-DFC3351B-039A-40A3-BBEC-BEF20EA2348A

P304

Q22242834-46E9AFC3-0386-4867-AEE3-C578ECA73F8E

P31

Q22242834-7811C1A4-294B-43B9-AEFA-35D377293C80

P356

Q22242834-3705372E-85B9-4909-915C-5D165FA5F8B6

P407

Q22242834-F76F08C9-384E-4550-A672-7692F9F34824

P433

Q22242834-C5B1610D-138E-4E10-B0C3-2AE8E8B9E1AA

P478

Q22242834-8F472AAB-9F5B-479F-92EB-B3ED2E1FFCE1

P50

Q22242834-13E00562-A22A-4063-B903-63D94B7FA51C

Q22242834-5F070BC9-4B98-4EB6-B622-CF37DF79DDC5

Q22242834-65E32B53-CC98-4B47-9128-945AE3DCEE0F

Q22242834-692EB9FA-E862-4FFD-8768-BFC412C19E03

Q22242834-82B55C36-2DF3-4BF3-8349-84584042E955

P577

Q22242834-9FC791FA-70C6-44A3-8277-7002F4BF854E

P5875

Q22242834-CEA45FFB-B263-4769-B9AE-83C3F6CE14BF

P698

Q22242834-4DE18B8F-9B8F-479E-9BF8-31F627335D00

P921

Q22242834-5A53C17B-86B8-4FBB-B6D9-09C156ED7A0E

Q22242834-6DF74E2D-53B4-47DE-8FD6-E6ECCB167B54

P932

Q22242834-C6D8678A-07F1-4106-A04C-C7D8BD8701CA

P356

P1433

Schizophrenia Bulletin

P1476

North American Prodrome Longit ...... odromal schizophrenia research

@en

P2093

Barbara Cornblatt

http://www.w3.org/2001/XMLSchema#string

Diana O Perkins

http://www.w3.org/2001/XMLSchema#string

Elaine F Walker

http://www.w3.org/2001/XMLSchema#string

Ming Tsuang

http://www.w3.org/2001/XMLSchema#string

Robert Heinssen

http://www.w3.org/2001/XMLSchema#string

Scott W Woods

http://www.w3.org/2001/XMLSchema#string

P2860

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design

Prevention of missing data in clinical research studies.

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.

Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.

Identification of separable cognitive factors in schizophrenia.

The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.

Strauss (1969) revisited: a psychosis continuum in the general population?

A selective review of recent North American long-term followup studies of schizophrenia.

Overcoming barriers to research in early serious mental illness: issues for future collaboration.

P304

665-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/SCHBUL/SBL075

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Thomas McGlashan

Kristin S Cadenhead

Larry J Seidman

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6549278

http://www.w3.org/2001/XMLSchema#string

P698

17255119

http://www.w3.org/2001/XMLSchema#string

P921

P932

2526151

http://www.w3.org/2001/XMLSchema#string